Free Webinar Tackles Obesity as a Chronic Disease in 2026
Free Webinar Tackles Obesity as a Chronic Disease in 2026
Free Webinar Tackles Obesity as a Chronic Disease in 2026
A new webinar titled Obesity Update 2026 will take place on March 18, 2026, at 8:00 PM, offering pharmacists the latest insights into obesity treatment. The free online event, part of the brand Webinars series, will cover scientific advancements, modern drug therapies, and the role of pharmacists in patient support.
Access is restricted to pharmacy professionals, with registration requiring confirmation of professional status under § 2 HWG (German Medicinal Products Advertising Act).
Obesity is widely misunderstood as a lifestyle choice rather than a chronic disease. This misconception often delays proper care and reinforces stigma. According to the 2023 German Health Atlas, around 10.2% of the population—roughly 8.6 million people—live with obesity, with women affected more frequently than men. The condition carries serious physical, psychological, and social consequences, demanding medical attention beyond simple weight management.
The webinar will explore innovative drug therapies that target the neurobiological roots of obesity. These treatments intervene in hormonal appetite control, satiety regulation, and metabolism. One highlighted medication, Mounjaro (tirzepatide, Lilly), mimics natural hormones to achieve effects beyond earlier approaches.
Dr. Dennis Ballwieser, a physician and obesity patient, will share personal experiences to underscore the need for respectful healthcare communication. Pharmacist Michael Becker will discuss practical support, including training patients on injection pens, encouraging treatment adherence, and fostering interdisciplinary teamwork. The event will also feature an open Q&A session, ensuring compliance with legal regulations for pharmacy professionals.
Registration remains open 24/7 via the brand Webinars platform at webinar.ourwebsite.
The Obesity Update 2026 webinar aims to equip pharmacists with updated knowledge on obesity as a chronic disease and the latest therapeutic options. By addressing stigma and improving patient care, the session seeks to enhance interdisciplinary collaboration.
Pharmacy teams can register at any time, provided they meet the professional requirements under German law.